Finance

Lists
RLAY:NASDAQ
Relay Therapeutics Inc
18,12 $
-0,33%
(-0,060) 1D
18,15 $
+0,17% (+0,030)
Pre-market
Closed: 26 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLAY...
Open
18,33 $
High
18,66 $
Low
17,94 $
Mkt. cap
3,97 մլրդ
Avg. vol.
2,96 մլն
Volume
4,77 հզր
52-wk high
21,27 $
52-wk low
5,95 $
EPS
-1,57 $
Beta
1,72
Shares outstanding
219,14 մլն
No. of employees
202
Open
18,33 $
High
18,66 $
Low
17,94 $
Mkt. cap
3,97 մլրդ
Avg. vol.
2,96 մլն
Volume
4,77 հզր
52-wk high
21,27 $
52-wk low
5,95 $
EPS
-1,57 $
Beta
1,72
Shares outstanding
219,14 մլն
No. of employees
202
News stories
From web sources and news partners
About Relay Therapeutics Inc
CEO-
Employees202
Founded2015
Headquarters-
Sector-
Analyst ratings
Based on 8 analysts giving stock ratings to RLAY in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for RLAY in the last 3 months.
Highest
Current 18,12 $
31,00 $ (+71,08%)
Average
27,14 $ (+49,78%)
Lowest
20,00 $ (+10,38%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
29,00 $
+60%
10/26/2026
Chi Meng Fong
Bank of America Securities
Buy
Maintained
25,00 $
+38%
10/23/2026
Boris Peaker
JonesTrading
Buy
Maintained
20,00 $
+10,4%
09/27/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
29,00 $
+60%
08/21/2026
Priyanka Grover
J.P. Morgan
Buy
Maintained
31,00 $
+71,1%
08/14/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
26,00 $
+43,5%
08/10/2026
Etzer Darout
Barclays
Buy
Maintained
30,00 $
+65,6%
08/07/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
08/06/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
31,00 $
+71,1%
07/20/2026
Unknown Analyst
J.P. Morgan
Buy
Initiated
28,00 $
+54,5%
07/08/2026
Bradley Canino
Guggenheim
Buy
Maintained
26,00 $
+43,5%
05/25/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Maintained
21,00 $
+15,9%
05/19/2026
Sean McCutcheon
Raymond James
Buy
Maintained
26,00 $
+43,5%
05/19/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
18,00 $
-0,7%
05/06/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
22,00 $
+21,4%
05/06/2026
Danya Ben-Hail
JonesTrading
Hold
Initiated
18,00 $
-0,7%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
7,00 մլն
3,00 մլն
350,00 հզր
Cost of goods sold
67,89 մլն
54,04 մլն
70,56 մլն
76,48 մլն
Cost of revenue
67,89 մլն
54,04 մլն
70,56 մլն
76,48 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,50 մլն
13,59 մլն
11,03 մլն
14,69 մլն
Operating expense
12,50 մլն
13,59 մլն
11,03 մլն
14,69 մլն
Total operating expenses
80,39 մլն
67,63 մլն
81,59 մլն
91,17 մլն
Operating income
-80,39 մլն
-60,63 մլն
-78,59 մլն
-90,82 մլն
Other non operating income
-165,00 հզր
30,00 հզր
-53,00 հզր
2,00 հզր
EBT including unusual items
-74,15 մլն
-54,89 մլն
-73,29 մլն
-83,71 մլն
EBT excluding unusual items
-74,15 մլն
-54,89 մլն
-73,29 մլն
-83,71 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-74,15 մլն
-54,89 մլն
-73,29 մլն
-83,71 մլն
Net profit margin
-
-784,14%
-2 443,03%
-23 916,29%
Earnings per share
-0,43
-0,31
-0,41
-0,41
Interest and investment income
6,41 մլն
5,71 մլն
5,35 մլն
7,12 մլն
Interest expense
-
-
-
-
Net interest expenses
6,41 մլն
5,71 մլն
5,35 մլն
7,12 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-79,64 մլն
-60,03 մլն
-78,09 մլն
-90,46 մլն
Gain or loss from assets sale
353,00 հզր
35,00 հզր
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps